SMR Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Operations Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns CANF Q4 2023 Earnings EPS Surprise of 96 as Biotech Reports NarrowerThanExpected Loss CMI Q1 2026 Earnings EPS Beats Estimates by 897 as Shares Rally PLTR Q1 2026 Earnings EPS Surges Past Estimates but Stock Declines Yueda Digital Holding YDKG Edges Higher as Consolidation Continues Near Key Support Carlyle Credit Income Fund CCIF Dips 22 Key Support Levels in Focus Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range Network1 Technologies NTIP Holds Near Resistance in Modest Uptick CXApp Inc CXAI Q1 2026 Earnings EPS Surprises Positively Amid Revenue Uncertainty